HWAM
SOPH icon

Hennion & Walsh Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Hennion & Walsh Asset Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
+98,347
New +$499K 0.02% 712

Other funds holding SOPH

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Hennion & Walsh Asset Management's SOPH Position: Q2 2026 in Review

Hennion & Walsh Asset Management opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 98,347 shares worth $567K. The stake represents 0.02% of the portfolio and ranks #712 among its holdings.

9 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Hennion & Walsh Asset Management held 98,347 shares of SOPHiA GENETICS worth $567K as of Q2 2026.
  • SOPHiA GENETICS was a new Hennion & Walsh Asset Management position in Q2 2026.
  • SOPHiA GENETICS made up 0.02% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #712 holding.
  • 9 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.